Chloe Atreya, MD, PhD
Dr. Chloe E. Atreya specializes in gastrointestinal cancer, particularly colorectal cancer, at the UCSF Helen Diller Comprehensive Cancer Center. Her research focuses on the interplay of tumor genetics and response to therapies for colorectal cancer, with the goal of improving patient outcomes and quality of life by personalizing treatment.
Originally from Ann Arbor, MI, she earned a BA in molecular biology and a Certificate in visual art from Princeton University. Dr. Atreya received her medical degree and Ph.D. in pharmacology at Yale University. Subsequently, she completed her internship and residency in internal medicine at University of Washington, Seattle and fellowship in medical oncology at UCSF, where she is now an Assistant Clinical Professor.
Dr. Atreya is the recipient of numerous prestigious awards, including the American Cancer Society Postdoctoral Fellowship, Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award and Alliance for Clinical Trials in Oncology Foundation Investigator Award. In 2014 she earned a certificate in Advanced Training in Clinical Research from the UCSF Clinical & Translational Science Institute. She is the recipient of a National Cancer Institute/National Institutes of Health K08 Career Development Award for Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models. Dr. Atreya is a member of the American Society of Clinical Oncologists, American Association of Cancer Researchers and Alliance for Clinical Trials in Oncology, Gastrointestinal Committee.